Company
Nexentis Technologies Inc. (NXTS)
Standardized SEC financial data for Nexentis Technologies Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001789192 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-20.3%
Return on equity
-25.4%
ROIC
-28.5%
Free cash flow
-$3.8M
Debt / equity
0.00×
Current ratio
4.19×
EPS (diluted)
$-8.61
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $232K | $438K | $394K | $263K | $210K | — |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $243K | $6.8M | $5.8M | $4.5M | $2.2M | $4.0M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$799K | -$4.1M | -$5.1M | -$3.2M | -$3.4M | -$3.8M |
| Capital expenditures |
Get NXTS data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/NXTS/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/NXTS/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"